HEADER HYDROLASE/HYDROLASE INHIBITOR 10-AUG-18 6EDR TITLE CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH 4'-THIORIBOSE NAD+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN RESIDUES 45-300; COMPND 5 SYNONYM: 2'-PHOSPHO-ADP-RIBOSYL CYCLASE,2'-PHOSPHO-ADP-RIBOSYL COMPND 6 CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE,2'-PHOSPHO-CYCLIC- COMPND 7 ADP-RIBOSE TRANSFERASE,ADP-RIBOSYL CYCLASE 1,ADPRC 1,CYCLIC ADP- COMPND 8 RIBOSE HYDROLASE 1,CADPR HYDROLASE 1,T10; COMPND 9 EC: 3.2.2.6,2.4.99.20; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFUSE MAMMALIAN KEYWDS INHIBITOR, CD38, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.DAI,X.N.ZHANG,F.NASERTORABI,Q.CHENG,H.PEI,S.G.LOUIE,C.R.STEVENS, AUTHOR 2 Y.ZHANG REVDAT 5 15-MAY-24 6EDR 1 COMPND HETNAM FORMUL REVDAT 4 11-OCT-23 6EDR 1 REMARK REVDAT 3 25-DEC-19 6EDR 1 REMARK REVDAT 2 13-NOV-19 6EDR 1 JRNL REVDAT 1 21-NOV-18 6EDR 0 JRNL AUTH Z.DAI,X.N.ZHANG,F.NASERTORABI,Q.CHENG,H.PEI,S.G.LOUIE, JRNL AUTH 2 R.C.STEVENS,Y.ZHANG JRNL TITL FACILE CHEMOENZYMATIC SYNTHESIS OF A NOVEL STABLE MIMIC OF JRNL TITL 2 NAD. JRNL REF CHEM SCI V. 9 8337 2018 JRNL REFN ISSN 2041-6520 JRNL PMID 30568770 JRNL DOI 10.1039/C8SC03899F REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 21875 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1176 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1574 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.64 REMARK 3 BIN R VALUE (WORKING SET) : 0.3370 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3893 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.09000 REMARK 3 B22 (A**2) : -3.04000 REMARK 3 B33 (A**2) : -0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.72000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.453 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.276 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.299 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 29.077 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4118 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3605 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5623 ; 1.420 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8369 ; 0.987 ; 3.007 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 498 ; 6.115 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 175 ;39.152 ;23.829 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 662 ;15.757 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;15.503 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 624 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4500 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 860 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 44 292 B 44 292 15346 0.070 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 44 A 292 REMARK 3 ORIGIN FOR THE GROUP (A): -13.3845 -4.9891 -6.7950 REMARK 3 T TENSOR REMARK 3 T11: 0.3781 T22: 0.0445 REMARK 3 T33: 0.0658 T12: -0.0017 REMARK 3 T13: -0.1380 T23: -0.0131 REMARK 3 L TENSOR REMARK 3 L11: 0.2891 L22: 0.4695 REMARK 3 L33: 0.1701 L12: -0.2414 REMARK 3 L13: 0.1476 L23: -0.1615 REMARK 3 S TENSOR REMARK 3 S11: 0.0638 S12: -0.0110 S13: -0.0327 REMARK 3 S21: -0.0038 S22: -0.0283 S23: 0.0541 REMARK 3 S31: -0.0026 S32: 0.0349 S33: -0.0355 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 44 B 292 REMARK 3 ORIGIN FOR THE GROUP (A): -9.9096 -25.4132 -39.4767 REMARK 3 T TENSOR REMARK 3 T11: 0.4443 T22: 0.0268 REMARK 3 T33: 0.0435 T12: 0.0172 REMARK 3 T13: -0.1136 T23: 0.0051 REMARK 3 L TENSOR REMARK 3 L11: 0.3522 L22: 0.5493 REMARK 3 L33: 0.1793 L12: 0.0709 REMARK 3 L13: -0.0218 L23: -0.1010 REMARK 3 S TENSOR REMARK 3 S11: 0.0686 S12: 0.0148 S13: 0.0304 REMARK 3 S21: -0.0091 S22: -0.0871 S23: -0.0443 REMARK 3 S31: 0.0293 S32: 0.0029 S33: 0.0185 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6EDR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1000235954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAR-18 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 7.0-7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRROR: FLAT SI RH COATED M0, REMARK 200 KIRKPATRICK-BAEZ FLAT BENT SI M1 REMARK 200 & M2 REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23158 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.395 REMARK 200 RESOLUTION RANGE LOW (A) : 99.948 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.700 REMARK 200 R MERGE (I) : 0.36800 REMARK 200 R SYM (I) : 0.36800 REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 8.70 REMARK 200 R MERGE FOR SHELL (I) : 1.06800 REMARK 200 R SYM FOR SHELL (I) : 1.46800 REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1ZVM REMARK 200 REMARK 200 REMARK: THIN PLATELETS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH 7.0, 14-18% PEG 4000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.55300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 293 REMARK 465 SER A 294 REMARK 465 SER A 295 REMARK 465 CYS A 296 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 GLY B 246 REMARK 465 ARG B 247 REMARK 465 GLU B 248 REMARK 465 ASP B 293 REMARK 465 SER B 294 REMARK 465 SER B 295 REMARK 465 CYS B 296 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 49 CD OE1 NE2 REMARK 470 GLN A 83 CD OE1 NE2 REMARK 470 GLU A 104 OE1 OE2 REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 LYS A 121 NZ REMARK 470 ASP A 130 CG OD1 OD2 REMARK 470 GLU A 162 CD OE1 OE2 REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 GLN A 171 CG CD OE1 NE2 REMARK 470 ARG A 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 247 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 248 OE1 OE2 REMARK 470 LYS A 260 NZ REMARK 470 ASP A 282 CG OD1 OD2 REMARK 470 GLN A 286 CD OE1 NE2 REMARK 470 LYS A 289 CE NZ REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 GLU A 292 CG CD OE1 OE2 REMARK 470 GLN B 49 OE1 NE2 REMARK 470 LYS B 57 CG CD CE NZ REMARK 470 GLU B 103 CG CD OE1 OE2 REMARK 470 LYS B 111 CD CE NZ REMARK 470 ASP B 130 CG OD1 OD2 REMARK 470 ARG B 140 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 162 CD OE1 OE2 REMARK 470 GLN B 171 CD OE1 NE2 REMARK 470 ARG B 177 CZ NH1 NH2 REMARK 470 LYS B 178 CD CE NZ REMARK 470 ARG B 212 CZ NH1 NH2 REMARK 470 SER B 213 OG REMARK 470 LYS B 214 CE NZ REMARK 470 LYS B 218 CG CD CE NZ REMARK 470 ASP B 249 CG OD1 OD2 REMARK 470 SER B 250 OG REMARK 470 ARG B 251 CZ NH1 NH2 REMARK 470 LYS B 260 CE NZ REMARK 470 LYS B 268 CG CD CE NZ REMARK 470 ARG B 280 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 282 CG OD1 OD2 REMARK 470 LYS B 283 CG CD CE NZ REMARK 470 GLN B 286 CG CD OE1 NE2 REMARK 470 VAL B 288 CG1 CG2 REMARK 470 LYS B 289 NZ REMARK 470 ASN B 290 CG OD1 ND2 REMARK 470 GLU B 292 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 128 58.79 -145.65 REMARK 500 VAL A 138 -60.00 -101.65 REMARK 500 ASP A 179 -72.37 -120.69 REMARK 500 ASP A 179 -72.37 -120.68 REMARK 500 ASP A 202 -106.30 58.19 REMARK 500 VAL A 225 -53.76 -121.98 REMARK 500 ASN A 270 48.69 70.82 REMARK 500 PRO B 98 30.19 -82.50 REMARK 500 ILE B 128 57.30 -147.55 REMARK 500 ASP B 179 -72.35 -121.22 REMARK 500 ASP B 202 -105.95 57.63 REMARK 500 VAL B 225 -53.10 -122.97 REMARK 500 ASN B 270 48.69 71.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZNA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZNA B 401 DBREF 6EDR A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 6EDR B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 6EDR SER A 44 UNP P28907 EXPRESSION TAG SEQADV 6EDR ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 6EDR ALA A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 6EDR ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 6EDR ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 6EDR SER B 44 UNP P28907 EXPRESSION TAG SEQADV 6EDR ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 6EDR ALA B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 6EDR ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 6EDR ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQRES 1 A 257 SER ARG TRP ARG GLN GLN TRP SER GLY PRO GLY THR THR SEQRES 2 A 257 LYS ARG PHE PRO GLU THR VAL LEU ALA ARG CYS VAL LYS SEQRES 3 A 257 TYR THR GLU ILE HIS PRO GLU MET ARG HIS VAL ASP CYS SEQRES 4 A 257 GLN SER VAL TRP ASP ALA PHE LYS GLY ALA PHE ILE SER SEQRES 5 A 257 LYS HIS PRO CYS ASP ILE THR GLU GLU ASP TYR GLN PRO SEQRES 6 A 257 LEU MET LYS LEU GLY THR GLN THR VAL PRO CYS ASN LYS SEQRES 7 A 257 ILE LEU LEU TRP SER ARG ILE LYS ASP LEU ALA HIS GLN SEQRES 8 A 257 PHE THR GLN VAL GLN ARG ASP MET PHE THR LEU GLU ASP SEQRES 9 A 257 THR LEU LEU GLY TYR LEU ALA ASP ASP LEU THR TRP CYS SEQRES 10 A 257 GLY GLU PHE ALA THR SER LYS ILE ASN TYR GLN SER CYS SEQRES 11 A 257 PRO ASP TRP ARG LYS ASP CYS SER ASN ASN PRO VAL SER SEQRES 12 A 257 VAL PHE TRP LYS THR VAL SER ARG ARG PHE ALA GLU ALA SEQRES 13 A 257 ALA CYS ASP VAL VAL HIS VAL MET LEU ASP GLY SER ARG SEQRES 14 A 257 SER LYS ILE PHE ASP LYS ASP SER THR PHE GLY SER VAL SEQRES 15 A 257 GLU VAL HIS ASN LEU GLN PRO GLU LYS VAL GLN THR LEU SEQRES 16 A 257 GLU ALA TRP VAL ILE HIS GLY GLY ARG GLU ASP SER ARG SEQRES 17 A 257 ASP LEU CYS GLN ASP PRO THR ILE LYS GLU LEU GLU SER SEQRES 18 A 257 ILE ILE SER LYS ARG ASN ILE GLN PHE SER CYS LYS ASN SEQRES 19 A 257 ILE TYR ARG PRO ASP LYS PHE LEU GLN CYS VAL LYS ASN SEQRES 20 A 257 PRO GLU ASP SER SER CYS THR SER GLU ILE SEQRES 1 B 257 SER ARG TRP ARG GLN GLN TRP SER GLY PRO GLY THR THR SEQRES 2 B 257 LYS ARG PHE PRO GLU THR VAL LEU ALA ARG CYS VAL LYS SEQRES 3 B 257 TYR THR GLU ILE HIS PRO GLU MET ARG HIS VAL ASP CYS SEQRES 4 B 257 GLN SER VAL TRP ASP ALA PHE LYS GLY ALA PHE ILE SER SEQRES 5 B 257 LYS HIS PRO CYS ASP ILE THR GLU GLU ASP TYR GLN PRO SEQRES 6 B 257 LEU MET LYS LEU GLY THR GLN THR VAL PRO CYS ASN LYS SEQRES 7 B 257 ILE LEU LEU TRP SER ARG ILE LYS ASP LEU ALA HIS GLN SEQRES 8 B 257 PHE THR GLN VAL GLN ARG ASP MET PHE THR LEU GLU ASP SEQRES 9 B 257 THR LEU LEU GLY TYR LEU ALA ASP ASP LEU THR TRP CYS SEQRES 10 B 257 GLY GLU PHE ALA THR SER LYS ILE ASN TYR GLN SER CYS SEQRES 11 B 257 PRO ASP TRP ARG LYS ASP CYS SER ASN ASN PRO VAL SER SEQRES 12 B 257 VAL PHE TRP LYS THR VAL SER ARG ARG PHE ALA GLU ALA SEQRES 13 B 257 ALA CYS ASP VAL VAL HIS VAL MET LEU ASP GLY SER ARG SEQRES 14 B 257 SER LYS ILE PHE ASP LYS ASP SER THR PHE GLY SER VAL SEQRES 15 B 257 GLU VAL HIS ASN LEU GLN PRO GLU LYS VAL GLN THR LEU SEQRES 16 B 257 GLU ALA TRP VAL ILE HIS GLY GLY ARG GLU ASP SER ARG SEQRES 17 B 257 ASP LEU CYS GLN ASP PRO THR ILE LYS GLU LEU GLU SER SEQRES 18 B 257 ILE ILE SER LYS ARG ASN ILE GLN PHE SER CYS LYS ASN SEQRES 19 B 257 ILE TYR ARG PRO ASP LYS PHE LEU GLN CYS VAL LYS ASN SEQRES 20 B 257 PRO GLU ASP SER SER CYS THR SER GLU ILE HET ZNA A 401 44 HET ZNA B 401 44 HETNAM ZNA [[(2~{R},3~{S},4~{R},5~{R})-5-(3-AMINOCARBONYLPYRIDIN- HETNAM 2 ZNA 1-IUM-1-YL)-3,4-BIS(OXIDANYL)THIOLAN-2-YL]METHOXY- HETNAM 3 ZNA OXIDANYL-PHOSPHORYL] [(2~{R},3~{S},4~{R},5~{R})-5-(6- HETNAM 4 ZNA AMINOPURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHYL HETNAM 5 ZNA HYDROGEN PHOSPHATE FORMUL 3 ZNA 2(C21 H28 N7 O13 P2 S 1+) FORMUL 5 HOH *87(H2 O) HELIX 1 AA1 ARG A 58 HIS A 74 1 17 HELIX 2 AA2 PRO A 75 ARG A 78 5 4 HELIX 3 AA3 ASP A 81 ILE A 94 1 14 HELIX 4 AA4 GLU A 103 ASP A 105 5 3 HELIX 5 AA5 TYR A 106 GLY A 113 1 8 HELIX 6 AA6 ILE A 128 GLN A 139 1 12 HELIX 7 AA7 THR A 144 ASP A 147 5 4 HELIX 8 AA8 THR A 148 ASP A 155 1 8 HELIX 9 AA9 ASN A 183 ALA A 200 1 18 HELIX 10 AB1 SER A 220 VAL A 225 1 6 HELIX 11 AB2 ASP A 256 ARG A 269 1 14 HELIX 12 AB3 ARG A 280 ASN A 290 1 11 HELIX 13 AB4 ARG B 58 HIS B 74 1 17 HELIX 14 AB5 PRO B 75 ARG B 78 5 4 HELIX 15 AB6 ASP B 81 ILE B 94 1 14 HELIX 16 AB7 GLU B 103 ASP B 105 5 3 HELIX 17 AB8 TYR B 106 GLY B 113 1 8 HELIX 18 AB9 ILE B 128 GLN B 139 1 12 HELIX 19 AC1 THR B 144 ASP B 147 5 4 HELIX 20 AC2 THR B 148 ASP B 155 1 8 HELIX 21 AC3 ASN B 183 ALA B 200 1 18 HELIX 22 AC4 SER B 220 VAL B 225 1 6 HELIX 23 AC5 ASP B 256 ARG B 269 1 14 HELIX 24 AC6 ARG B 280 ASN B 290 1 11 SHEET 1 AA1 2 GLY A 52 PRO A 53 0 SHEET 2 AA1 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 AA2 4 LEU A 123 SER A 126 0 SHEET 2 AA2 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 AA2 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 AA2 4 GLN A 272 ILE A 278 1 O ILE A 278 N VAL A 242 SHEET 1 AA3 2 GLY B 52 PRO B 53 0 SHEET 2 AA3 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 AA4 4 LEU B 123 SER B 126 0 SHEET 2 AA4 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 AA4 4 VAL B 235 ILE B 243 1 O TRP B 241 N VAL B 206 SHEET 4 AA4 4 GLN B 272 ILE B 278 1 O ILE B 278 N VAL B 242 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.12 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.07 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.11 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.10 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.06 SSBOND 6 CYS B 67 CYS B 82 1555 1555 2.09 SSBOND 7 CYS B 99 CYS B 180 1555 1555 2.07 SSBOND 8 CYS B 119 CYS B 201 1555 1555 2.09 SSBOND 9 CYS B 160 CYS B 173 1555 1555 2.10 SSBOND 10 CYS B 254 CYS B 275 1555 1555 2.05 SITE 1 AC1 9 TRP A 125 SER A 126 ARG A 127 LEU A 145 SITE 2 AC1 9 GLU A 146 TRP A 189 SER A 193 THR A 221 SITE 3 AC1 9 PHE A 222 SITE 1 AC2 12 TRP B 125 SER B 126 ARG B 127 LEU B 145 SITE 2 AC2 12 GLU B 146 VAL B 185 TRP B 189 SER B 193 SITE 3 AC2 12 THR B 221 PHE B 222 GLU B 226 HOH B 508 CRYST1 57.742 51.106 100.674 90.00 96.89 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017319 0.000000 0.002091 0.00000 SCALE2 0.000000 0.019567 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010005 0.00000